RCC HOLDINGS CORP news, videos and press releases
For more news please use our advanced search feature.
RCC HOLDINGS CORP - More news...
RCC HOLDINGS CORP - More news...
- European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC)
- KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) Reduced Risk of Death by Nearly Half Compared to Sunitinib as First-Line Treatment for Advanced Renal Cell Carcinoma (RCC)
- WATCH: President Donald Trump Makes Remarks At RCC Dinner - Tuesday March 20, 2018 | CNBC
- SillaJen Poster Presentation at 2018 GU ASCO Symposium Highlights New Clinical Data in RCC, Intravenous Delivery of Pexa-Vec, Oncolytic Immunotherapy
- PUDO and Retail Council of Canada ("RCC") working together to make delivery easier for retailers and their customers